The Next 100 Days Podcast Podcast By Kevin Appleby & Graham Arrowsmith cover art

The Next 100 Days Podcast

The Next 100 Days Podcast

By: Kevin Appleby & Graham Arrowsmith
Listen for free

The Next 100 Days Podcast is a leading UK business show. Through this podcast, Kevin and Graham reveal strategies you can use to improve your business and take it to the next level. In addition to featuring their own advice, Kevin and Graham host amazing guests from across the business world. Often the guests are successful, but lesser-known business owners and entrepreneurs, enabling the show to bring fresh content and stand out from many of the US based business shows. Graham and Kevin believe that business change comes about when a business owner focusses on just one thing that will make a real difference to his business. That might be product development, a new product launch or a marketing campaign. Focussing for less than 100 days, or focussing on too many things generally won't deliver the results you need, Equally, its difficult to maintain effective focus for much longer than 100 days without re-assessing priorities. The Next 100 Days Podcast is your source to learn how to move your business forward, with practical advice and guidance that you can put into action and make a difference in your own organisation within the next 100 days.Copyright 2026 Kevin Appleby & Graham Arrowsmith Economics Leadership Management Management & Leadership Personal Finance
Episodes
  • #520 - Jason Wong - Packaging

    #520 - Jason Wong - Packaging
    Apr 10 2026

    Packaging expert Jason Wong shares his background, starting as a young entrepreneur selling things online and eventually discovering his passion for packaging and manufacturing. He describes how he bought factories in China to produce packaging for various consumer brands, leveraging his marketing expertise to expand the business.

    Summary of PodcastThe impact of tariffs on Jason's business

    Jason discusses the challenges his business faced when new tariffs were imposed on Chinese imports, but explains how they adapted and remained competitive by highlighting the cost savings they could still offer clients compared to domestic manufacturing.

    Automation and AI in packaging

    Jason talks about how his business is leveraging automation and AI technology to improve efficiency and productivity in the packaging process, including using AI agents to handle various administrative and research tasks.

    Potential collaboration opportunities

    Graham shares ideas for potential collaboration between his marketing services and Jason's packaging expertise, particularly around creating unique "shock and awe" packaging experiences to promote certain products and reach high-net-worth individuals.

    Packaging as a powerful marketing tool

    Graham and Jason explore the importance of packaging as a branding and marketing tool, discussing how the packaging can create a perception of quality and value for products. They identify opportunities to use packaging creatively to reach and engage target audiences.

    The Next 100 Days Podcast Co-Hosts

    Graham Arrowsmith

    Graham founded Finely Fettled in 2014 to provide data from The UK High Net Worth Database to marketers targeting affluent and high-net-worth customers. He's the founder of MicroYES, a Partner for MeclabsAI, creating lead generation AI Agents & Workflows and introducing the MeclabsAI Platform. Graham also provides an Answer Engine Optimisation solution to get your website in shape to be found by LLMs.

    Kevin Appleby

    Kevin specialises in finance transformation and implementing business change. He's the COO of GrowCFO, which provides both community and CPD-accredited training designed to grow the next generation of finance leaders. You can find Kevin on LinkedIn and at kevinappleby.com
    Show more Show less
    42 mins
  • #519 - Ed Cappabianca - Ingenion Medical

    #519 - Ed Cappabianca - Ingenion Medical
    Apr 3 2026
    Ingenion Medical, run by our guest Ed Cappabianca, is going to change the standard catheter in the UK - The Foley catheter. Urinary catheter-associated infections kill 2,100 people a year and block 1.2 million hospital bed-days. And yet, the Foley catheter - the standard of care - has barely changed in 91 years. Ingenion Medical has built what replaces it.The cymactive™ 2.0R is a CE-marked, patient-controlled urethral catheter with a patented magnetic valve that is already in clinical use across the UK and 15 international markets. It is superior to either standard Foleys or intermittent catheters, and generates revenue today. Ingenion Medical are seeking investors. Here's the Investment case:• Revenue generative, regulatory approved. CE Mark achieved Q1 2024. ISO 13485 renewed October 2025. FDA pre-sub meeting completed.• Commercial traction. Distributor agreements in over 10 countries. NHS Supply Chain at contract award stage. 15 NHS hospitals active or in pipeline.• Profitable at 1,600 patients per month (80 urologists x 20 patients). Breakeven H2 2027. £49m revenue projected 2030.• Exit precedent. Comparable urology acquisitions: Urotronic > Laborie $600m;Neotract > Teleflex $1.1b; Augmenix > Boston Scientific $600m; .• World-class advisors. Advisory board includes: Professor Chris Chapple (former European Association of Urology Secretary General) and Professor Kurt Naber, global authority on urinary tract infections.If you would like the detailed Investor Pitch Deck, go to: ingenion.approvedinvestors.co.ukSummary of PodcastKey TakeawaysThe Problem: Current catheters cause frequent, costly infections (£2k–£3.5k per cycle for the NHS) and severely limit patient mobility and quality of life.The Solution: Ingenion's cymactive catheter is a 30-day, self-voiding device with no external bag, restoring patient dignity and designed to reduce infection risk.Market Validation: The NHS created a new framework channel specifically for SimActive, signaling strong support for its innovation and cost-saving potential.The Ask: Ingenion is raising £2M (for ~10% equity) to fund commercialisation, targeting a future trade sale to a major urology firm for a potential 10x investor return.The Problem with Current CathetersUrinary Retention: A common condition caused by issues like BPH (enlarged prostate), Parkinson's, MS, and spinal cord injuries.Foley Catheter (Indwelling):The 100-year-old standard, anchored by an internal balloon.Creates a "superhighway for bacteria," causing frequent, costly infections.Full cost of ownership for the NHS is ~£800/month per patient.Intermittent Catheters (Single-Use):Used 5–8 times daily, creating significant waste and inconvenience.Account for 90% (£157.5M) of the NHS's £175M annual catheter spend.Patient Impact:Fear of infection and public voiding → social isolation.Reduced fluid intake → dehydration, which can worsen conditions like dementia.The cymactive SolutionInnovation: A 30-day, self-voiding catheter with no external tubes or bags.Mechanism:An internal, patient-controlled magnetic valve.An external magnet opens the valve; removing it allows the valve to close naturally.Infection Defense:The urethra seals over the valve's end, mimicking the body's natural defense against bacteria.Anecdotal evidence suggests reduced infections and restored function.Product Pipeline:Current: cymactive for male urinary retention (CE marked).In Development: Versions for women and for male incontinence.Market Validation & CommercialisationNHS Adoption:The NHS created a new framework channel for cymactive, as it didn't fit existing categories.Ingenion was the sole applicant and signed a 2-year contract on March 12, 2026.Ordering codes are now live for hospitals.Go-to-Market Strategy:Goal: Build awareness among clinicians and patient groups.Method: Target early adopters and use their case studies, shared by the NHS innovation team, to drive broader adoption.Rationale: A randomised control trial was unfeasible because Foley catheter users were unwilling to risk being randomised to the control group.Investment OpportunityThe Ask: £2M for ~10% equity (pre-money valuation: £18M).Exit Strategy: Trade sale to a major urology firm (e.g., Coloplast, Becton Dickinson).Rationale: Leverage a large firm's infrastructure for rapid, global scaling.Target Return: A typical venture capital return of ~10x investment.Investor Profile: High Net Worth (HNW) or Sophisticated Investors.Due Diligence: Pitch deck available at ingenion.approvedinvestors.co.ukThe Next 100 Days Podcast Co-HostsGraham ArrowsmithGraham founded Finely Fettled in 2014 to provide data from The UK High Net Worth Database to marketers targeting affluent and high-net-worth customers. He's the founder of MicroYES, a Partner for MeclabsAI, creating lead generation AI Agents & Workflows and introducing the MeclabsAI Platform. Graham also provides an Answer Engine Optimisation solution to get your website in shape to be found ...
    Show more Show less
    1 hr
  • #518 Carmen Sederino - Illuminated Story

    #518 Carmen Sederino - Illuminated Story
    Mar 27 2026

    Carmen Sederino’s holistic approach to her Illuminated Story approach combines narrative structure, stage presence, and multimedia elements to create immersive, encore-worthy shows that resonate deeply with audiences. Drab speakers are a thing of the past!

    Summary of Podcast

    Introduction to Carmen and her background

    Graham introduces Carmen Sederino, who is joining the podcast from Australia. Carmen shares her background, including her formal training in theater and performing arts, as well as her extensive corporate experience leading marketing and branding teams.

    Carmen's approach to helping clients with presentations

    Carmen explains how she works with clients, often high-level executives, to transform their presentations and speaking skills. She focuses on crafting compelling stories and messages, as well as helping them develop their stage presence and delivery.

    Practical tips for improving presentations

    Carmen provides specific examples and techniques she uses to help clients, such as having them practice delivering content in different personas or styles to expand their range, and using pauses and energy to create more impact.

    Carmen's business and the power of storytelling

    Graham and Carmen discuss the "Illuminated Story" brand and Carmen's focus on helping clients illuminate their stories and expertise through engaging presentations. They touch on the importance of storytelling in business communication.

    Kevin's upcoming presentation challenge

    Kevin shares that he is working on a presentation on a dry topic (ethics and governance) and asks Carmen for advice on how to make it more engaging and impactful.

    The Next 100 Days Podcast Co-Hosts

    Graham Arrowsmith

    Graham founded Finely Fettled in 2014 to provide data from The UK High Net Worth Database to marketers targeting affluent and high-net-worth customers. He's the founder of MicroYES, a Partner for MeclabsAI, creating lead generation AI Agents & Workflows and introducing the MeclabsAI Platform. Graham also provides an Answer Engine Optimisation solution to get your website in shape to be found by LLMs.

    Kevin Appleby

    Kevin specialises in finance transformation and implementing business change. He's the COO of GrowCFO, which provides both community and CPD-accredited training designed to grow the next generation of finance leaders. You can find Kevin on LinkedIn and at kevinappleby.com
    Show more Show less
    49 mins
No reviews yet